Heart Disease Trial, Recruiting NCT05931614 Sponsor: Region Stockholm Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05931614
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with left-sided heart failure where the heart muscle is weakened (specifically the types known as HFrEF or HFmEF).
  • People who are physically able, mentally able, and able to communicate in the study language well enough to take part in all parts of the study.

Who may not be able to join:

  • People whose heart failure is caused by a treatable underlying condition, such as a thyroid problem or severe anaemia.
  • People who have very low sodium (salt) levels in their blood at the start of the study (below 130 mmol/L).
  • People whose kidneys are not working well enough at the start of the study, as measured by a specific kidney function test (confirm with trial site for exact details).
  • People who are scheduled to have heart surgery or a procedure on their heart arteries within the next 3 months.
  • People who have had a heart attack within the last 3 months.
  • People who have another health condition that means their doctor has advised them to either strictly limit or have no limits on how much fluid they drink.
  • People whose life expectancy is less than 6 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carolin Nymark, PhD, Karolinska Universitetssjukhuset, Heart and Vascular Center

Phone: +46725955887

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Stockholm
Registry
ClinicalTrials.gov
Start date
14 February 2024
Est. completion
1 December 2028

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

B-lines; NT-proBNP

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov